- Home
- FDMT vs CVRX Comparison
FDMT vs CVRX Comparison
Compare FDMT & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- CVRX
- Stock Information
- Founded
- FDMT 2013
- CVRX 2000
- Country
- FDMT United States
- CVRX United States
- Employees
- FDMT N/A
- CVRX N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FDMT Health Care
- CVRX Health Care
- Exchange
- FDMT Nasdaq
- CVRX Nasdaq
- Market Cap
- FDMT 207.1M
- CVRX 174.4M
- IPO Year
- FDMT 2020
- CVRX 2021
- Fundamental
- Price
- FDMT $4.13
- CVRX $5.89
- Analyst Decision
- FDMT Buy
- CVRX Buy
- Analyst Count
- FDMT 10
- CVRX 7
- Target Price
- FDMT $32.33
- CVRX $14.50
- AVG Volume (30 Days)
- FDMT 449.2K
- CVRX 236.3K
- Earning Date
- FDMT 08-07-2025
- CVRX 07-28-2025
- Dividend Yield
- FDMT N/A
- CVRX N/A
- EPS Growth
- FDMT N/A
- CVRX N/A
- EPS
- FDMT N/A
- CVRX N/A
- Revenue
- FDMT $23,000.00
- CVRX $52,870,000.00
- Revenue This Year
- FDMT $13,048.65
- CVRX $11.53
- Revenue Next Year
- FDMT N/A
- CVRX $18.61
- P/E Ratio
- FDMT N/A
- CVRX N/A
- Revenue Growth
- FDMT N/A
- CVRX 25.62
- 52 Week Low
- FDMT $2.24
- CVRX $4.30
- 52 Week High
- FDMT $28.93
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- FDMT 54.45
- CVRX 41.15
- Support Level
- FDMT $4.21
- CVRX $5.54
- Resistance Level
- FDMT $4.62
- CVRX $5.96
- Average True Range (ATR)
- FDMT 0.30
- CVRX 0.40
- MACD
- FDMT -0.02
- CVRX -0.03
- Stochastic Oscillator
- FDMT 37.42
- CVRX 21.99
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.